Prospective, Comprehensive, and Effective Viral Monitoring in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Autor: Schönberger, S., Meisel, R., Adams, O., Pufal, Y., Laws, H.J., Enczmann, J., Dilloo, D.

Publikováno v: In Biology of Blood and Marrow Transplantation 2010 16(10):1428-1435

High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008

Autor: Whelan, J., Deley, M.C. le, Dirksen, U., Teuff, G. le, Brennan, B., Gaspar, N., Hawkins, D.S., Amler, S., Bauer, S., Bielack, S., Blay, J.Y., Burdach, S., Castex, M.P., Dilloo, D., Eggert, A., Gelderblom, H., Gentet, J.C., Hartmann, W., Hassenpflug, W.A., Hjorth, L., Jimenez, M., Klingebiel, T., Kontny, U., Kruseova, J., Ladenstein, R., Laurence, V., Lervat, C., Marec-Berard, P., Marreaud, S., Michon, J., Morland, B., Paulussen, M., Ranft, A., Reichardt, P., Berg, H. van den, Wheatley, K., Judson, I., Lewis, I., Craft, A., Juergens, H., Oberlin, O., Euro- E W I N G 99 Investigator, EWING-2008 Investigator

Publikováno v: Journal of Clinical Oncology
Journal of Clinical Oncology, 36(31), 3110
Journal of clinical oncology, 36(31), 3110-3119. American Society of Clinical Oncology

Purpose For over 30 years, the place of consolidation high-dose chemotherapy in Ewing sarcoma (ES) has been controversial. A randomized study was conducted to determine whether consolidation high-dose chemotherapy improved survival in patients with l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96eb6ac761dbaef5b72b0d7cac093a0c
https://doi.org/10.1200/jco.2018.78.2516

Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial

Autor: LOCATELLI F, NOLLKE P, ZECCA M, KORTHOF E, LANINO E, PETERS C, KABISCH H, UDERZO C, BONFIM CS, BADER P, DILLOO D, STARY J, FISCHER A, REVESZ T, FUHRER M, HASLE H, TREBO M, VAN DEN HEUVEL EIBRINK MM, FENU S, STRAHM B, GIORGIANI G, BONORA MR, DUFFNER U, NIEMEYER CM, EUROPEAN WORKING GROUP ON CHILDHOOD MDS, EUROPEAN BLOOD AND MARROW TRANSPLANTATION GROUP, PESSION, ANDREA

Publikováno v: Locatelli, F, Nöllke, P, Zecca, M, Korthof, E, Lanino, E, Peters, C, Pession, A, Kabisch, H, Uderzo, C, Bonfim, CS, Bader, P, Dilloo, D, Stary, J, Fischer, A, Revesz, T, Führer, M, Hasle, H, Trebo, M, Heuvel-Eibrink, MM, Fenu, S, Strahm, B, Giorgiani, G, Bonora, MR, Duffner, U & Niemeyer, CM 2005, ' Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial ', Blood, vol. 105, pp. 410-419 .
Blood, 105(1), 410-419. American Society of Hematology

Allogeneic hematopoietic stem cell transplantation (HSCT) is the only proven curative therapy for juvenile myelomonocytic leukemia (JMML). We, the European Working Group on Childhood MDS (EWOG-MDS) and the European Blood and Marrow Transplantation (E

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::505f7b5b301d88c559e49421637f3653
https://doi.org/10.1182/blood-2004-05-1944

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.